Open AccessPolydatin prevents bleomycin‑induced pulmonary fibrosis by inhibiting the TGF‑β/Smad/ERK signaling pathway
Author(s) -
Yanlu Liu,
Bao-Yi Chen,
Juan Nie,
GuangHui Zhao,
Jian-Yi Zhuo,
Jie Yuan,
Yucui Li,
Lingli Wang,
Zhiwei Chen
Publication year - 2020
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2020.9190
Subject(s) - bleomycin , pulmonary fibrosis , resveratrol , pirfenidone , medicine , fibrosis , hydroxyproline , idiopathic pulmonary fibrosis , smad , transforming growth factor , cancer research , pharmacology , pathology , chemistry , lung , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom